<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 11901 - Juvenile amyotrophic lateral sclerosis</h1></div><div><p><b>Other Names: </b>Amyotrophic lateral sclerosis, juvenile, JALS, Juvenile Charcot disease, Juvenile Lou Gehrig disease</p><p><b>Categories: </b><span> Congenital and Genetic Diseases</span><span> Nervous System Diseases</span><!----></p><p><b>This disease is grouped under: </b>Amyotrophic lateral sclerosis</p><p><b>Summary: </b><span><strong>Juvenile amyotrophic lateral sclerosis</strong> (JALS) is a rare&nbsp;<a href="https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet" target="_blank">motor neuron disease</a> characterized by progressive degeneration of upper and lower motor neurons. Motor neurons are nerve cells that control voluntary muscle activity.[13408] Symptoms of JALS typically begin before age 25, but often in early childhood.[13408][13409] Symptoms include facial spasticity, dysarthria, and a spastic gait (manner of walking). Some people have uncontrolled laughter and weeping, mild wasting of the legs and hands, bladder dysfunction, and/or sensory disturbances.[13408] The disease is usually slowly progressive but rate of progression varies.[13409] People with JALS may become unable to move by age 12 to age 50.[13408]<br>
<br>
JALS includes several subtypes, distinguished by the specific variations (mutations) in any of several genes, including:[13408][13409]
<ul>
    <li><span><a href="https://www.omim.org/entry/205100" target="_blank">ALS2</a> caused by mutations in the </span><em><span><a href="https://ghr.nlm.nih.gov/gene/ALS2" target="_blank"><span>ALS2</span></a></span></em><span>&nbsp;gene</span></li>
    <li><span><a href="https://omim.org/entry/614373" target="_blank">ALS16</a> caused by mutations in the<em> <a href="https://ghr.nlm.nih.gov/gene/SIGMAR1" target="_blank"><span>SIGMAR1</span></a></em></span><span>&nbsp;gene</span></li>
    <li><span><a href="https://www.omim.org/entry/602099" target="_blank">ALS5</a> caused by mutations in the<em> <a href="https://ghr.nlm.nih.gov/gene/SPG11" target="_blank"><span>SPG11</span></a></em></span><span>&nbsp;gene</span></li>
    <li><span><a href="https://omim.org/entry/602433" target="_blank">ALS4</a> caused by mutation in the<em> <a href="https://ghr.nlm.nih.gov/gene/SETX" target="_blank"><span>SETX</span></a></em></span><span>&nbsp;gene</span></li>
</ul>
<span>There are some reports of&nbsp; JALS caused by mutations in the&nbsp;&nbsp;</span><span><em><span><a href="https://ghr.nlm.nih.gov/gene/UBQLN2" target="_blank">UBQLN2</a>&nbsp;</span></em></span><span>(related to ALS15), <em><a href="https://ghr.nlm.nih.gov/gene/FUS" target="_blank"><span>FUS</span></a></em></span><span>&nbsp;(related to ALS6) and&nbsp;</span><em><a href="https://ghr.nlm.nih.gov/gene/TARDBP" target="_blank"><span>TARDBP</span></a></em><span>&nbsp;(related to ALS10) genes.[13408][13409][14655][14656]</span>
<p>Mutations may be inherited from a parent or may occur for the first time in a person with the disease.[13409] Inheritance may be autosomal recessive or autosomal dominant depending on the gene involved.[13408][13409]<br>
<br>
There is no specific treatment for JALS. Management generally involves physical and occupational therapy to promote mobility and independence.[13408]<br>
<br>
</p></span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Muscular Dystrophy Association - ALS Division</a></span><br><span>3300 East Sunrise Drive</span><br><span>Tucson AZ, 85718-3208</span><br><!----><!----></li><li><span><a href="org.url">Amyotrophic Lateral Sclerosis Society of Canada</a></span><br><span>265 Yorkland Boulevard</span><br><span> , </span><br><!----><!----></li><li><span><a href="org.url">The ALS Association</a></span><br><span>1275 K Street, N.W.</span><br><span>Washington, DC , 20005</span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.ncbi.nlm.nih.gov/omim?term=%28juvenile[Title]%29%20AND%20amyotrophic%20lateral%20sclerosis[Title]" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%28juvenile[Title/Abstract]%20AND%20amyotrophic[Title/Abstract]%20AND%20lateral[Title/Abstract]%20AND%20sclerosis[Title/Abstract]%29%20AND%20%28%222003/07/09%22[PDat]%20%3A%20%222013/07/05%22[PDat]%29&amp;amp;cmd=DetailsSearch" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Juvenile amyotrophic lateral sclerosis. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=300605" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>The <a target="_blank" href="https://www.rarediseasesnetwork.org/CREATE/index.htm">Clinical Research in Amyotrophic Lateral Sclerosis and Related Disorders for Therapeutic Development (CREATE) Consortium</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving sporadic and familial forms of amyotrophic lateral sclerosis, frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and progressive muscular atrophy (PMA). The CREATE Consortium has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the research projects.
<br>
<br>
For more information on the registry see: <a target="_blank" href="https://www.rarediseasesnetwork.org/registry/index.htm">https://www.rarediseasesnetwork.org/registry/index.htm</a></span></li><li><span>The <a href="https://monarchinitiative.org/disease/Orphanet:300605" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span><a href="https://www.patientservicesinc.org/patients/access-program" target="_blank">Patient Services, Inc (PSI)</a> provides financial support and guidance for qualified patients with specific chronic diseases. PSI helps patients find solutions to the social and economic problems confronting patients with chronic conditions.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>